[In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].

de Mouzon, J; Allavena, E; Schmitt, C; Frappé, M

[In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost]. / La fécondation in vitro en France. Approche économique et influence du choix des gonadotrophines (urinaires ou recombinantes) sur le coût.

de Mouzon, J; Allavena, E; Schmitt, C; Frappé, M.

Affiliation

de Mouzon J; Inserm U569, hôpital de Bicêtre, 78, avenue du Général-Leclerc, 94272 Le Kremlin-Bicêtre, France. demouzon@vjf.inserm.fr

Gynecol Obstet Fertil ; 32(6): 508-18, 2004 Jun.

Article in Fr | MEDLINE | ID: mdl-15217566

Subject(s)

Fertilization in Vitro/economics; Fertilization in Vitro/methods; Follicle Stimulating Hormone/economics; Costs and Cost Analysis; Drug Costs; Embryo Transfer; Female; Follicle Stimulating Hormone/administration & dosage; Follicle Stimulating Hormone/urine; France; Humans; Ovulation Induction/methods; Pregnancy; Recombinant Proteins/economics

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Fertilization in Vitro / Follicle Stimulating Hormone Type of study: Clinical_trials / Health_economic_evaluation Limits: Female / Humans / Pregnancy Country/Region as subject: Europa Language: Fr Journal: Gynecol Obstet Fertil Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2004 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links